Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SANOFI-4698/news/Media-Update-Patient-enrollment-of-phase-III-tolebrutinib-trials-paused-in-the-U-S-40861046/?utm_source=whatsapp&utm_medium=social&utm_campaign=share